SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

688098 (688098) News

Track canonical SquawkNews coverage tagged to 688098, 688098. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 688098 Asset market Sector Markets 90 days 1 Updated Sep 20, 2026, 07:53 AM UTC Open live news feed
M Shanghai Shen Lian says UB-221 phase II trial hits primary endpoint Shanghai Shen Lian Biomedical Corp (SSE:688098) says its Phase II clinical trial of UB-221 met its primary endpoint. EQUITY | Sep 20, 2026, 07:53 AM UTC